172 related articles for article (PubMed ID: 8787909)
1. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins.
Viladrich PF; Cabellos C; Pallares R; Tubau F; Martínez-Lacasa J; Liñares J; Gudiol F
Antimicrob Agents Chemother; 1996 Jan; 40(1):218-20. PubMed ID: 8787909
[TBL] [Abstract][Full Text] [Related]
2. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.
Jacobs RF; Kaplan SL; Schutze GE; Dajani AS; Leggiadro RJ; Rim CS; Puri SK
Antimicrob Agents Chemother; 1996 Apr; 40(4):895-8. PubMed ID: 8849247
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
Tan TQ; Schutze GE; Mason EO; Kaplan SL
Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.
Friedland IR; Klugman KP
Antimicrob Agents Chemother; 1997 Sep; 41(9):1888-91. PubMed ID: 9303379
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.
Doit C; Barre J; Cohen R; Bonacorsi S; Bourrillon A; Bingen EH
Antimicrob Agents Chemother; 1997 Sep; 41(9):2050-2. PubMed ID: 9303415
[TBL] [Abstract][Full Text] [Related]
6. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
7. Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae.
Guibert M; Chahime H; Petit J; Odièvre M; Labrune P
Acta Paediatr; 1995 Jul; 84(7):831-3. PubMed ID: 7549311
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
[No Abstract] [Full Text] [Related]
9. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia.
Buckingham SC; Brown SP; Joaquin VH
J Pediatr; 1998 Jan; 132(1):174-6. PubMed ID: 9470026
[TBL] [Abstract][Full Text] [Related]
11. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
Täuber MG; Hackbarth CJ; Scott KG; Rusnak MG; Sande MA
Antimicrob Agents Chemother; 1985 Mar; 27(3):340-2. PubMed ID: 3838872
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci.
Viladrich PF; Gudiol F; Liñares J; Rufi G; Ariza J; Pallares R
Am J Med; 1988 May; 84(5):839-46. PubMed ID: 3364443
[TBL] [Abstract][Full Text] [Related]
13. [Meningitis by Streptococcus pneumoniae: resistant to cefotaxime?].
Fernández-Fernández FJ; García-Rodríguez JF; Sesma P; González-González C
Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):45-6. PubMed ID: 10069118
[No Abstract] [Full Text] [Related]
14. Cefotaxime failure in pneumococcal meningitis caused by a susceptible isolate.
Flórez C; Silva G; Martín E
Pediatr Infect Dis J; 1996 Aug; 15(8):723-4. PubMed ID: 8858688
[No Abstract] [Full Text] [Related]
15. Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults.
Martínez E; Miró JM; Almirante B; Aguado JM; Fernandez-Viladrich P; Fernandez-Guerrero ML; Villanueva JL; Dronda F; Moreno-Torrico A; Montejo M; Llinares P; Gatell JM;
Clin Infect Dis; 2002 Jul; 35(2):130-9. PubMed ID: 12087518
[TBL] [Abstract][Full Text] [Related]
16. Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone.
Le Turnier P; Tattevin P; Varon E; Duval X
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0001223. PubMed ID: 36880753
[No Abstract] [Full Text] [Related]
17. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance.
Fiore AE; Moroney JF; Farley MM; Harrison LH; Patterson JE; Jorgensen JH; Cetron M; Kolczak MS; Breiman RF; Schuchat A
Clin Infect Dis; 2000 Jan; 30(1):71-7. PubMed ID: 10619736
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
Chesney PJ; Davis Y; English BK; Wang WC
Pediatr Infect Dis J; 1995 Nov; 14(11):1013-5. PubMed ID: 8584345
[No Abstract] [Full Text] [Related]
19. A case of penicillin-resistant pneumococcal meningitis.
Earnest R
J Tenn Med Assoc; 1996 Apr; 89(4):121. PubMed ID: 8867231
[No Abstract] [Full Text] [Related]
20. Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis.
Pacheco TR; Cooper CK; Hardy DJ; Betts RF; Bonnez W
Am J Med; 1997 Mar; 102(3):303-5. PubMed ID: 9217602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
